Geron to Announce First Quarter 2024 Financial Results on May 2, 2024

Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on

Businesswire16:30 ET

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (NASDAQ:GERN), a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 243,000 shares of Geron common stock as

BusinesswireApr 18 16:30 ET

Argan Reports Upbeat Earnings, Joins Coupang And Other Big Stocks Moving Higher On Friday

U.S. stocks were lower, with the Dow Jones index falling over 250 points on Friday. Shares of Argan, Inc. (NYSE:AGX) rose sharply during Friday's session as the company reported better-than-expected

BenzingaApr 12 10:19 ET

Express News | Geron Option Alert: Jun 21 $3 Calls at the Ask: 600 @ $1.15 Vs 8051 OI; Earnings 5/9 Before Open [Est] Ref=$4.0

Moomoo 24/7Apr 12 10:07 ET

Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future

Yahoo FinanceApr 11 08:48 ET

Jim Cramer: This Tech Stock Is "Great," Archer Aviation Is 'Too Speculative For Me'

On CNBC's "Mad Money Lightning Round," Jim Cramer said "no" to MarineMax Inc (NYSE:HZO). "It's just too risky right here," he noted. On March 11, MarineMax announced a new stock repurchase program o

BenzingaApr 11 08:37 ET